Lung Disease News and Research

RSS

South Australian-developed SARS-CoV-2 vaccine shows promise to prevent COVID-19 lung infection

A South Australian-developed SARS-CoV-19 vaccine is preparing to progress to the final stages of human clinical trials after early animal testing confirmed its safety and effectiveness in preventing COVID-19 lung infection.

12 Aug 2021

Risk factors for hospitalization among HIV patients infected with SARS-CoV-2

The hospitalization of PWH with COVID-19 is related to host factors such as older age and co-morbidities, rather than due to traditional metrics of HIV.

11 Aug 2021

Study shows impaired SARS-CoV-2 mRNA vaccine antibody response in individuals with chronic conditions

A recent study in Colorado used real-world data to evaluate if individuals with chronic conditions have reduced antibody response to COVID-19 mRNA vaccines. The study investigated whether some medical conditions may impact antibody response to the mRNA vaccines.

9 Aug 2021

Researchers discover potential biomarker for lung disease in scleroderma patients

Researchers have discovered a protein that may predict disease severity for a lung condition that often proves fatal to patients with scleroderma.

3 Aug 2021

CHOP researchers identify two proteins that could be used for a potential NTHi vaccine

Scientists at Children's Hospital of Philadelphia have identified two proteins that could be used for a potential vaccine against nontypeable Haemophilus influenzae (NTHi).

2 Aug 2021

Injecting mice with pulmonary endothelial cells can reverse symptoms of emphysema

Researchers at Weill Cornell Medicine and NewYork-Presbyterian in New York have discovered that injecting mice with pulmonary endothelial cells-the cells that line the walls of blood vessels in the lung-can reverse the symptoms of emphysema.

21 Jul 2021

Study evaluates physical activity and sedentary behavior in relation to OSA risk

Being more physically active and spending fewer hours per day sitting watching TV is linked to a substantially lower risk of developing obstructive sleep apnea (OSA), according to new research published in the European Respiratory Journal

21 Jul 2021

Yeast expressed, RBD-based vaccine provides robust immune responses against SARS-CoV-2

The ongoing coronavirus disease (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused over 190 million cases worldwide. Of these, over 4 million have died due to the infection.

20 Jul 2021

Single-cell RNA sequencing reveals cells that could protect from fatal lung disease

Single-cell RNA sequencing has revealed a subset of cells that could provide protection from a rare, but severely debilitating and fatal, lung disease.

16 Jul 2021

Researchers discover new set of signals that control production of goblet cells in the lung

Proper lung function relies on the precise balance of specialized epithelial cells (cells that line the surfaces of the body) that coordinate functions to maintain homeostasis.

13 Jul 2021

Real-world evidence SARS-CoV-2 mRNA vaccines work and help prevent worst outcomes

Researchers in the United States have conducted a study demonstrating the real-world effectiveness of the Pfizer-BioNTech BNT162b2 and Moderna mRNA-1273 vaccines at preventing hospitalizations due to coronavirus disease 2019 (COVID-19).

12 Jul 2021

Many coal miners suffering from black lung disease struggle with mental-health issues

More than a third of coal miners and former coal miners suffering from black lung disease struggle with depression, and more than one in 10 has recently considered suicide, a new study finds.

8 Jul 2021

Gene-edited cellular therapeutics can successfully treat cardiovascular and pulmonary diseases

Scientists at UC San Francisco have shown that gene-edited cellular therapeutics can be used to successfully treat cardiovascular and pulmonary diseases, potentially paving the way for developing less expensive cellular therapies to treat diseases for which there are currently few viable options.

6 Jul 2021

BU awarded T32 grant to mentor research trainees in lung biology and pulmonary sciences

Boston University School of Medicine's longest NIH-funded research training program, "Biology of the Lung: A Multi-Disciplinary Program," has been awarded a five-year, T32 grant to provide multidisciplinary training and exposure to collaborative lung biology in three scientific areas that are special strengths at Boston University: Development and Regenerative Medicine; Immunology and Infection; and Biomedical Data Sciences.

1 Jul 2021

Lung Disease News and Research

South Australian-developed SARS-CoV-2 vaccine shows promise to prevent COVID-19 lung infection

Risk factors for hospitalization among HIV patients infected with SARS-CoV-2

Study shows impaired SARS-CoV-2 mRNA vaccine antibody response in individuals with chronic conditions

Researchers discover potential biomarker for lung disease in scleroderma patients

CHOP researchers identify two proteins that could be used for a potential NTHi vaccine

Injecting mice with pulmonary endothelial cells can reverse symptoms of emphysema

Study evaluates physical activity and sedentary behavior in relation to OSA risk

Yeast expressed, RBD-based vaccine provides robust immune responses against SARS-CoV-2

Single-cell RNA sequencing reveals cells that could protect from fatal lung disease

Researchers discover new set of signals that control production of goblet cells in the lung

Real-world evidence SARS-CoV-2 mRNA vaccines work and help prevent worst outcomes

Many coal miners suffering from black lung disease struggle with mental-health issues

Gene-edited cellular therapeutics can successfully treat cardiovascular and pulmonary diseases

BU awarded T32 grant to mentor research trainees in lung biology and pulmonary sciences

Is COVID-19 more severe in pregnancy?

Young home isolated people have persistent symptoms six months after acute COVID-19

Western diet increases COVID-19 severity in a hamster model

Baseline use of DMARDs linked with COVID-19 severity in rheumatoid arthritis patients

Inhibiting necroptosis could be a novel approach for treating COPD

Nanoparticle-based therapy alleviates pulmonary hypertension in mouse model of rare lung disease

The ultimate guide to lung research tools and protocols eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News